To check Oneindia News on your Mobile
go to:   http://m.oneindia.in/news/
  •  

Biocon Q2 net profit down 54 per cent

 [IST]
Biocon
Mumbai, Oct 16: Biotechnology firm Biocon on Thursday, Oct 16 announced a consolidated net profit of Rs 25.02 crore for the second quarter ended September 30 compared to 53.97 crore in FY08 due to rupee volatility. It saw a decline of 54 per cent from year-ago period.

Biocon informed the Bombay Stock Exchange that its net sales rose to Rs 439.30 crore for the quarter under review, from Rs 263.66 crore last year. On a standalone basis, Biocon posted a net profit of Rs 33.53 crore for the quarter ended September 30, compared with Rs 44.01 crore for the same period last year. Total Income of the company increased to Rs 268.27 crore for the second quarter this fiscal from Rs 241.32 crore a year ago.

"Biocon's H1'09 performance has shown resilience despite being impacted by rupee volatility, which has seen us make mark-to-market provision of Rs 60 crore," Biocon Chairman and Managing Director Kiran Mazumdar Shaw said.



OneIndia News
Topics: biocon, net profit, rupee volatility, second quarter, bombay stock exchange
Other articles published on October 16, 2008

Biotechnology major Biocon forays into nephrology space

Friday, March 9, 2007,12:21 [IST]
Bangalore, Mar 09:  Biotechnology major Biocon on Thursday forayed into the nephrology space with the launch of a portfolio of five renal therapy products for the domestic and global markets, which it said was cheaper compared to MNC drug prices. The new immunosuppressants for renal therapy are at least 35-40 per cent cheaper than the MNC drug prices in the similar product category, the company's Marketing Head Rakesh Bamzai said.The Bangalore-headquartered company's Chairman and Managing Director, Kiran Mazumdar-Shaw said.....
Read More

Leading Asia-Pacific Biotech meet on June 7

Monday, June 4, 2007,17:15 [IST]
Bangalore, Jun 4: Growing in size and strength every year, the premier Biotech event of the country, Bangalore Bio 2007 will kick off here on June seven with over 150 companies from 12 countries participating in the much sought after event of the Asia Pacific region.The three day show to be inaugurated by Finance Miniter P Chidambaram will showcase globally the increasing biotech strength of the country. As many as eleven states would have presence in the event for which.....
Read More

Biocon eyes acquisition by March '08

Monday, December 3, 2007,14:06 [IST]
New Delhi, Dec 3: Biocon Ltd, country's fully integrated healthcare company, plans to acquire a firm by the end of the current financial year to boost its business in overseas markets. ''We are looking at US, Europe and some of the emerging markets,'' company's Chairman Kiran Mazumdar-Shaw told reporters at India Economic Summit jointly organised by the World Economic Forum and CII here today. The Bangalore-based firm has six pharmaceutical products in its discovery pipeline, and that Biocon plans to launch.....
Read More
User Comments
[ Post Comments ]
Be the first to comment on this article.
Oneindia  Oneindia Login
People Talk
ISHWAR GOELonAkhilesh's wife Dimple Yadav to contest Kannauj LS bypoll
HarionCynical calculations behind petrol price hike
babu singhonLIC of India launches Jeevan Vriddhi policy
mpenduloonFacebook Video Chat: How to start, Tips & Tricks
bhavanaonBank trade unions threaten to go on 2-day stir in July

Video Gallery